Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross CorpfiledCriticalGreen Cross Corp
Priority to DK475681ApriorityCriticalpatent/DK153865C/en
Publication of DK475681ApublicationCriticalpatent/DK475681A/en
Publication of DK153865BpublicationCriticalpatent/DK153865B/en
Application grantedgrantedCritical
Publication of DK153865CpublicationCriticalpatent/DK153865C/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Preparation of an immunoglobulin, which is suitable for intravenous injection, by means of a plasma or fraction I+II+III, fraction II+III, fraction II or fraction III, obtained from a plasma by means of Cohn's cold alcohol fractionation method, being treated with an acid and being subjected to fractionation using an alkylene oxide polymer or copolymer having a molecular weight of 2 000- 20 000. This results in a high yield of a very pure immunoglobulin of the non-aggregate type which essentially does not contain any immunoglobulin of the aggregate type.
DK475681A1981-10-281981-10-28
PROCEDURE FOR PREPARING IMMUNOGLOBULIN SUITABLE FOR INTRAVENOES INJECTION
DK153865C
(en)
Inhibition of in vivo growth of murine plasmacytoma MOPC-460 by monoclonal anti-idiotypic antibodies directed at distinct idiotypes of the immunoglobulin on the surface of MOPC-460